Advertisement

Virchows Archiv

, Volume 467, Issue 1, pp 119–121 | Cite as

Multifocal cytokeratin expression in pleural and abdominal malignant solitary fibrous tumors: an unusual diagnostic pitfall

  • Evelyne LecoutereEmail author
  • David Creytens
Letter to the Editor

Dear Editor,

Solitary fibrous tumor (SFT) is an uncommon mesenchymal fibroblastic neoplasm usually arising in the pleura, but it can virtually affect any extrapleural site. Conventional SFTs are characterized by short, cytologically bland spindle cells arranged in a patternless architecture, a fibro-collagenous stroma, and a prominent hemangiopericytomatous branching vascular network [1]. The vast majority of SFTs are morphologically and clinically benign. However, 5 to 10 % of SFTs will recur and/or metastasize. Proposed prognostic clinical and morphological criteria for SFT include age at presentation, tumor size, cellularity, mitotic activity (>4 mitoses per 10 high-power fields), the presence of necrosis, and the presence of sharply demarcated anaplastic areas. The vast majority of aggressive SFTs demonstrate these clinical and morphological features of malignancy; however, also morphologically benign-appearing SFTs can metastasize, and therefore, the biological behavior of this...

Keywords

Solitary Fibrous Tumor Cytokeratin Expression CD34 Reactivity Atypical Spindle Cell Malignant Solitary Fibrous Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) World Health Organization classification of tumours. Pathology and genetics. Tumours of soft tissue and bone. IARC, LyonGoogle Scholar
  2. 2.
    Demicco E, Park M, Araujo D et al (2012) Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25:1298–1306PubMedCrossRefGoogle Scholar
  3. 3.
    Chmielecki C, Crago AM, Rosenberg M et al (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Doyle LA, Vivero M, Fletcher CD et al (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27:390–395PubMedCrossRefGoogle Scholar
  5. 5.
    Yoshida A, Tsuta K, Ohno M et al (2014) STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 38:552–559PubMedCrossRefGoogle Scholar
  6. 6.
    Yan B, Raju GC, Salto-Tellez M (2008) Epithelioid, cytokeratin expressing malignant solitary fibrous tumour of the pleura. Pathology 40:98–99PubMedCrossRefGoogle Scholar
  7. 7.
    Cavazza A, Rossi G, Agostini L et al (2003) Cytokeratin-positive malignant solitary fibrous tumour of the pleura: an unusual pitfall in the diagnosis of pleural spindle cell neoplasms. Histopathology 43:606–608PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of PathologyGhent University and Ghent University HospitalGhentBelgium

Personalised recommendations